These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33303533)

  • 1. Machine learning can predict disease manifestations and outcomes in lymphangioleiomyomatosis.
    Chernbumroong S; Johnson J; Gupta N; Miller S; McCormack FX; Garibaldi JM; Johnson SR
    Eur Respir J; 2021 Jun; 57(6):. PubMed ID: 33303533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphangioleiomyomatosis in patients with tuberous sclerosis: a national centre audit.
    Johnson J; Somerfield W; Johnson SR
    Orphanet J Rare Dis; 2024 Mar; 19(1):137. PubMed ID: 38532450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging clinical picture of lymphangioleiomyomatosis.
    Cohen MM; Pollock-BarZiv S; Johnson SR
    Thorax; 2005 Oct; 60(10):875-9. PubMed ID: 16055626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of angiomyolipoma in lymphangioleiomyomatosis: implications for screening and surveillance.
    Yeoh ZW; Navaratnam V; Bhatt R; McCafferty I; Hubbard RB; Johnson SR
    Orphanet J Rare Dis; 2014 Oct; 9():151. PubMed ID: 25277108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical predictors of mortality and cause of death in lymphangioleiomyomatosis: a population-based registry.
    Oprescu N; McCormack FX; Byrnes S; Kinder BW
    Lung; 2013 Feb; 191(1):35-42. PubMed ID: 23007140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hierarchical cluster analysis based on disease-associated manifestations of patients with lymphangioleiomyomatosis: An analysis of the national database of designated intractable diseases of Japan.
    Hayashida M; Kinjo T; Wada Y; Kitaguchi Y; Hanaoka M
    Respir Investig; 2022 Jul; 60(4):570-577. PubMed ID: 35428607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting Individualized Lung Disease Progression in Treatment-Naive Patients With Lymphangioleiomyomatosis.
    Palipana AK; Gecili E; Song S; Johnson SR; Szczesniak RD; Gupta N
    Chest; 2023 Jun; 163(6):1458-1470. PubMed ID: 36610667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberous Sclerosis Complex: State-of-the-Art Review with a Focus on Pulmonary Involvement.
    von Ranke FM; Zanetti G; e Silva JL; Araujo Neto CA; Godoy MC; Souza CA; Mançano AD; Souza AS; Escuissato DL; Hochhegger B; Marchiori E
    Lung; 2015 Oct; 193(5):619-27. PubMed ID: 26104489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NHLBI LAM Registry: Prognostic Physiologic and Radiologic Biomarkers Emerge From a 15-Year Prospective Longitudinal Analysis.
    Gupta N; Lee HS; Ryu JH; Taveira-DaSilva AM; Beck GJ; Lee JC; McCarthy K; Finlay GA; Brown KK; Ruoss SJ; Avila NA; Moss J; McCormack FX;
    Chest; 2019 Feb; 155(2):288-296. PubMed ID: 29940164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphangioleiomyomatosis and multifocal micronodular pneumocyte hyperplasia in Japanese patients with tuberous sclerosis complex.
    Tanaka M; Hirata H; Wataya-Kaneda M; Yoshida M; Katayama I
    Respir Investig; 2016 Jan; 54(1):8-13. PubMed ID: 26718139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P).
    Urban T; Lazor R; Lacronique J; Murris M; Labrune S; Valeyre D; Cordier JF
    Medicine (Baltimore); 1999 Sep; 78(5):321-37. PubMed ID: 10499073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience of lymphangioleiomyomatosis in the UK.
    Johnson SR; Tattersfield AE
    Thorax; 2000 Dec; 55(12):1052-7. PubMed ID: 11083892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumothorax in a female with renal angiomyolipoma.
    Wu PH; Hwang DY; Kuo MC; Hwang SJ; Chen HC
    Kaohsiung J Med Sci; 2011 Oct; 27(10):469-72. PubMed ID: 21943821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphangioleiomyomatosis and tuberous sclerosis.
    Hancock E; Tomkins S; Sampson J; Osborne J
    Respir Med; 2002 Jan; 96(1):7-13. PubMed ID: 11863212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The TSC-2 product tuberin is expressed in lymphangioleiomyomatosis and angiomyolipoma.
    Johnson SR; Clelland CA; Ronan J; Tattersfield AE; Knox AJ
    Histopathology; 2002 May; 40(5):458-63. PubMed ID: 12010366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberous sclerosis complex presenting as pulmonary lymphangioleiomyomatosis--a clinicoradiological diagnosis.
    Gupta K; Goyal A; Saggar K; Banerjee A
    Pan Afr Med J; 2015; 20():207. PubMed ID: 26113938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 4-year prospective evaluation of protocols to improve clinical outcomes for patients with lymphangioleiomyomatosis in a national clinical centre.
    Bee J; Bhatt R; McCafferty I; Johnson SR
    Thorax; 2015 Dec; 70(12):1202-4. PubMed ID: 26123659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis.
    Bissler JJ; McCormack FX; Young LR; Elwing JM; Chuck G; Leonard JM; Schmithorst VJ; Laor T; Brody AS; Bean J; Salisbury S; Franz DN
    N Engl J Med; 2008 Jan; 358(2):140-51. PubMed ID: 18184959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in Polyamine Metabolism in Patients With Lymphangioleiomyomatosis and Tuberous Sclerosis Complex 2-Deficient Cells.
    Tang Y; El-Chemaly S; Taveira-Dasilva A; Goldberg HJ; Bagwe S; Rosas IO; Moss J; Priolo C; Henske EP
    Chest; 2019 Dec; 156(6):1137-1148. PubMed ID: 31299246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphangioleiomyomatosis: a review of the literature.
    Hancock E; Osborne J
    Respir Med; 2002 Jan; 96(1):1-6. PubMed ID: 11863203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.